Literature DB >> 32017286

Tumor immune microenvironment in head and neck cancers.

Samantha M Y Chen1, Alexandra L Krinsky1, Rachel A Woolaver1, Xiaoguang Wang1, Zhangguo Chen1, Jing H Wang1.   

Abstract

Head and neck cancers are a heterogeneous group of tumors that are highly aggressive and collectively represent the sixth most common cancer worldwide. Ninety percent of head and neck cancers are squamous cell carcinomas (HNSCCs). The tumor microenvironment (TME) of HNSCCs consists of many different subsets of cells that infiltrate the tumors and interact with the tumor cells or with each other through various networks. Both innate and adaptive immune cells play a crucial role in mediating immune surveillance and controlling tumor growth. Here, we discuss the different subsets of immune cells and how they contribute to an immunosuppressive TME of HNSCCs. We also briefly summarize recent advances in immunotherapeutic approaches for HNSCC treatment. A better understanding of the multiple factors that play pivotal roles in HNSCC tumorigenesis and tumor progression may help define novel targets to develop more effective immunotherapies for patients with HNSCC.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  cancer immunotherapy; head and neck cancers; tumor microenvironment; tumor-infiltrating lymphocytes

Mesh:

Year:  2020        PMID: 32017286      PMCID: PMC7282929          DOI: 10.1002/mc.23162

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  130 in total

1.  Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Authors:  Beatriz M Carreno; Vincent Magrini; Michelle Becker-Hapak; Saghar Kaabinejadian; Jasreet Hundal; Allegra A Petti; Amy Ly; Wen-Rong Lie; William H Hildebrand; Elaine R Mardis; Gerald P Linette
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

Review 2.  Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha; Daniel W Beury; Virginia K Clements
Journal:  Semin Cancer Biol       Date:  2012-02-01       Impact factor: 15.707

Review 3.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Authors:  Daniele Maggioni; Lorenzo Pignataro; Werner Garavello
Journal:  Oncoimmunology       Date:  2017-05-04       Impact factor: 8.110

4.  CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.

Authors:  Tatiana A Karakasheva; George A Dominguez; Ayumi Hashimoto; Eric W Lin; Christopher Chiu; Kate Sasser; Jae W Lee; Gregory L Beatty; Dmitry I Gabrilovich; Anil K Rustgi
Journal:  JCI Insight       Date:  2018-03-22

Review 5.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

Authors:  Douglas Marvel; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

6.  Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade.

Authors:  Tavi Nathanson; Arun Ahuja; Alexander Rubinsteyn; Bulent Arman Aksoy; Matthew D Hellmann; Diana Miao; Eliezer Van Allen; Taha Merghoub; Jedd D Wolchok; Alexandra Snyder; Jeff Hammerbacher
Journal:  Cancer Immunol Res       Date:  2016-12-12       Impact factor: 11.151

7.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Authors:  Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

8.  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Authors:  Matthew M Gubin; Xiuli Zhang; Heiko Schuster; Etienne Caron; Jeffrey P Ward; Takuro Noguchi; Yulia Ivanova; Jasreet Hundal; Cora D Arthur; Willem-Jan Krebber; Gwenn E Mulder; Mireille Toebes; Matthew D Vesely; Samuel S K Lam; Alan J Korman; James P Allison; Gordon J Freeman; Arlene H Sharpe; Erika L Pearce; Ton N Schumacher; Ruedi Aebersold; Hans-Georg Rammensee; Cornelis J M Melief; Elaine R Mardis; William E Gillanders; Maxim N Artyomov; Robert D Schreiber
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

Review 9.  The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.

Authors:  Emma J de Ruiter; Marc L Ooft; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2017-08-09       Impact factor: 8.110

10.  Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.

Authors:  Jan Boucek; Tomas Mrkvan; Martin Chovanec; Martin Kuchar; Jaroslav Betka; Vladimir Boucek; Marie Hladikova; Jan Betka; Tomas Eckschlager; Blanka Rihova
Journal:  J Cell Mol Med       Date:  2009-01-14       Impact factor: 5.310

View more
  20 in total

1.  Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.

Authors:  Désirée Gül; Andrea Schweitzer; Aya Khamis; Shirley K Knauer; Guo-Bin Ding; Laura Freudelsperger; Ioannis Karampinis; Sebastian Strieth; Jan Hagemann; Roland H Stauber
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

2.  Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.

Authors:  Sonia Furgiuele; Géraldine Descamps; Jerome R Lechien; Didier Dequanter; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

3.  Identification of a novel ceRNA network related to prognosis and immunity in HNSCC based on integrated bioinformatic investigation.

Authors:  Hongbo Liu; Guoli Hei; Lu Zhang; Yanxia Jiang; Haijun Lu
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell-like properties and phosphoinositide 3-kinase inhibitor insensitivity.

Authors:  Khoa A Nguyen; Madison J Keith; Stephen B Keysar; Spencer C Hall; Anamol Bimali; Antonio Jimeno; Xiao-Jing Wang; Christian D Young
Journal:  Mol Carcinog       Date:  2022-04-13       Impact factor: 5.139

5.  Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck.

Authors:  Yuying Zhu; Shikang Zheng; Xingyou Zhai; Cheng Wang; Aijun Liu; Jun Ju; Xin Peng; Liwei Chen; Yongxia Zhang; Nan Ren; Yingli Xie; Junda Fan; Kai Zhao; Mingbo Liu
Journal:  J Immunol Res       Date:  2022-04-18       Impact factor: 4.493

6.  Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.

Authors:  Rachel A Woolaver; Xiaoguang Wang; Alexandra L Krinsky; Brittany C Waschke; Samantha M Y Chen; Vince Popolizio; Andrew G Nicklawsky; Dexiang Gao; Zhangguo Chen; Antonio Jimeno; Xiao-Jing Wang; Jing Hong Wang
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

7.  Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma.

Authors:  Hideyuki Takahashi; Koichi Sakakura; Shota Ida; Reika Kawabata-Iwakawa; Toshiyuki Matsuyama; Hiroe Tada; Ikko Mito; Kazuaki Chikamatsu
Journal:  Cancer Sci       Date:  2021-11-16       Impact factor: 6.716

8.  A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.

Authors:  Yi Zhang; Ping Chen; Qiang Zhou; Hongyan Wang; Qingquan Hua; Jie Wang; Hongliang Zhong
Journal:  Front Genet       Date:  2021-06-18       Impact factor: 4.599

Review 9.  Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Authors:  Qiang Xu; Meiyu Fang; Jing Zhu; Haoru Dong; Jun Cao; Lin Yan; Fransisca Leonard; Felix Oppel; Holger Sudhoff; Andreas M Kaufmann; Andreas E Albers; Xu Qian
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

10.  Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.

Authors:  Samantha M Y Chen; Bian Li; Andrew G Nicklawsky; Alexandra L Krinsky; Tonya Brunetti; Rachel A Woolaver; Xiaoguang Wang; Zhangguo Chen; Christian D Young; Dexiang Gao; Xiao-Jing Wang; Jing H Wang
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.